LEGAL-CARE: Legal Support for Cancer Patients

This study, called LEGAL-CARE, is looking at how legal support can help people with advanced cancer. Many cancer patients face legal challenges like getting disability benefits, dealing with employment rules, or understanding health insurance. This study will test a program where a legal navigator (a lawyer) will proactively reach out to you monthly for six months to help with these issues. The goal is to see if this type of legal support is practical and helpful. You might be able to join if you are an adult (18 or older) with a new diagnosis of advanced stage cancer (stages III or IV) that needs systemic treatment. The study is currently unclear on its recruitment status.

Study design
This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 50 participants.
What's involved
Participants will receive monthly outreach from a trained legal navigator over a 6-month period.
Compensation
Not stated in the trial record.
Follow-up
The primary goal is measured at 6 months, which suggests the main follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07197515

Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)

Recruiting
NAAges 18+InterventionalSupportive care
University of Alabama at Birmingham
~50 participants
Updated 2026-02-06 on ClinicalTrials.gov
What's tested:Legal Navigation

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility Benchmarks
Measured over 6 months
Cancer
1 sites across 1 states
Alabama1
  • Qasim M Hussaini, MD, MS · PRINCIPAL_INVESTIGATOR · University of Alabama at Birmingham

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

New de novo advanced stage cancer (stages III/IV) requiring systemic therapy..

Exclusion

non-melanoma skin cancer
benign cancer or in-situ tumor
a recurrence of a previously diagnosed cancer
a hospice encounter in the past year
those unable to complete surveys
unable to communicate fluently in English
unable to provide consent in English
  • Feasibility Benchmarks6 months

    Feasibility will be measured by 1. retention of ≥70% of enrolled patients at 6 months and 2. ≥75% completion of biweekly surveys among retained patients. Acceptability will be measured by the Acceptability of Intervention Measure (AIM), 4 items on a 5-point Likert scale (1-5; higher = more acceptable). Appropriateness will be measured by the Intervention Appropriateness Measure (IAM), 4 items on a 5-point Likert scale (1-5; higher = more appropriate). Feasibility (perceptions) will be measured by the Feasibility of Intervention Measure (FIM), 4 items on a 5-point Likert scale (1-5; higher = more feasible).